Patents by Inventor Christophe Masselon

Christophe Masselon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bladder cancer biomarker proteins
    Patent number: 11536724
    Abstract: The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: December 27, 2022
    Assignees: POLYQUANT GMBH, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS, LUXEMBOURG INSTITUTE OF HEALTH, INSTITUT CURIE, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO
    Inventors: Jerome Garin, Christophe Masselon, Antonia Vlahou, Manousos Makrydakis, Ieronimos Zoidakis, Bruno Domon, Elodie Duriez, Aurelie Kamoun, Francois Radvanyi, Yves Allory, Nuria Malats Riera, Mirari Marquez Cid, Magali Court
  • BLADDER CANCER BIOMARKER PROTEINS
    Publication number: 20180372754
    Abstract: The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Type: Application
    Filed: December 23, 2016
    Publication date: December 27, 2018
    Inventors: Jerome GARIN, Christophe MASSELON, Antonia VLAHOU, Manousos MAKRYDAKIS, Ieronimos ZOIDAKIS, Bruno DOMON, Elodie DURIEZ, Aurelie KAMOUN, Francois RADVANYI, Yves ALLORY, Nuria MALATS RIERA, Mirari MARQUEZ CID, Magali COURT
  • Device for determining the mass of a particle in suspension or in solution in a fluid
    Patent number: 9506852
    Abstract: A device is provided for determining the mass of a particle in suspension or in solution in a fluid, including a first device for the nebulization of the fluid to obtain a flux comprising at least the particle; a second device for the guidance and the aerodynamic focusing of the flux; and a third device for determining the mass of the particle by a frequency measurement, the third device including at least one gravimetric detector, arranged opposite an outlet of the second device, to receive the particle.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: November 29, 2016
    Assignee: Commissariat a l'energie atomique et aux energies alternatives
    Inventors: Sebastien Hentz, Christophe Masselon
  • DEVICE FOR DETERMINING THE MASS OF A PARTICLE IN SUSPENSION OR IN SOLUTION IN A FLUID
    Publication number: 20140250980
    Abstract: Device for determining the mass of a particle in suspension or in solution in a fluid. Said device comprises: a first device (2) for the nebulization of the fluid (4) to obtain a flux comprising at least the particle, a second device (6) for the guidance and the aerodynamic focusing of the flux and a third device (12) for determining the mass of the particle by a frequency measurement, said third device comprising at least one gravimetric detector (14), arranged opposite the outlet of the second device, to receive the particle.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 11, 2014
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT
    Inventors: Sebastien Hentz, Christophe Masselon